Most-Cited Full-Text Articles http://opp.sagepub.com/ Most-cited rankings are recalculated at the beginning of the month and are based on citations to articles on this journal site from articles in other HighWire-hosted journals. 2008-10-05 <![CDATA[How to protect environment and employees against cytotoxic agents, the UZ Ghent experience]]> http://opp.sagepub.com/cgi/content/short/6/4/146?rss=1&ssource=mfc Jan 1, 2001; 6:146-152
Article]]> Johan Vandenbroucke, Hugo Robays 2001-01-01 10.1177/107815520100600403 SAGE Publications <![CDATA[External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers]]> http://opp.sagepub.com/cgi/content/short/9/1/15?rss=1&ssource=mfc Mar 1, 2003; 9:15-20
Article]]> Bertrand Favier, Laurence Gilles, Claude Ardiet, Jean Francois Latour 2003-03-01 10.1191/1078155203jp102oa SAGE Publications <![CDATA[Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans]]> http://opp.sagepub.com/cgi/content/short/12/3/179?rss=1&ssource=mfc Sep 1, 2006; 12:179-181
Article]]> Myke R Green, Claudio Anasetti, Ramon L Sandin, Nancy E Rolfe, John N Greene 2006-09-01 10.1177/1078155206069165 SAGE Publications <![CDATA[Comparative contamination study with cyclophosphamide, fluorouracil and ifosfamide: standard technique versus a proprietary closed-handling system]]> http://opp.sagepub.com/cgi/content/short/10/4/217?rss=1&ssource=mfc Dec 1, 2004; 10:217-223
Article]]> Birgit Tans, Ludo Willems 2004-12-01 10.1191/1078155204jp140oa SAGE Publications <![CDATA[Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective]]> http://opp.sagepub.com/cgi/content/short/11/3/101?rss=1&ssource=mfc Sep 1, 2005; 11:101-109
Article]]> Heidi Schulz, Susan Bigelow, Roxanne Dobish, Carole R Chambers 2005-09-01 10.1191/1078155205jp152oa SAGE Publications <![CDATA[Rationalisation of chemotherapy services in the University Hospital Birmingham National Health Science Trust]]> http://opp.sagepub.com/cgi/content/short/4/1/10?rss=1&ssource=mfc Mar 1, 1998; 4:10-14
Article]]> James P. Baker, Sarah E. Jones 1998-03-01 10.1177/107815529800400101 SAGE Publications <![CDATA[5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy]]> http://opp.sagepub.com/cgi/content/short/12/4/201?rss=1&ssource=mfc Dec 1, 2006; 12:201-209
Article]]> Gerald M Higa, Miklos L Auber, Ramin Altaha, Debbie Piktel, Sohba Kurian, Gerry Hobbs, Kenneth Landreth 2006-12-01 10.1177/1078155206072080 SAGE Publications <![CDATA[Fatigue in cancer patients treated with cytotoxic drugs]]> http://opp.sagepub.com/cgi/content/short/12/3/155?rss=1&ssource=mfc Sep 1, 2006; 12:155-164
Article]]> Per Hartvig, Johan Aulin, Matilda Hugerth, Sofia Wallenberg, Gunnar Wagenius 2006-09-01 10.1177/1078155206070774 SAGE Publications <![CDATA[Management of hand-foot syndrome induced by capecitabine]]> http://opp.sagepub.com/cgi/content/short/12/3/131?rss=1&ssource=mfc Sep 1, 2006; 12:131-141
Article]]> Sarah M Gressett, Brad L Stanford, Fred Hardwicke 2006-09-01 10.1177/1078155206069242 SAGE Publications <![CDATA[Zoledronic acid versus pamidronate as palliative therapy in cancer patients: A Canadian time and motion analysis]]> http://opp.sagepub.com/cgi/content/short/7/1/27?rss=1&ssource=mfc Mar 1, 2001; 7:27-33
Article]]> George Dranitsaris, Liana D Castel, Jean Francois Baladi, Kevin A Schulman 2001-03-01 10.1191/1078155201jp077oa SAGE Publications <![CDATA[The effect of isopropyl alcohol on the permeation of gloves exposed to antineoplastic agents]]> http://opp.sagepub.com/cgi/content/short/6/3/109?rss=1&ssource=mfc Sep 1, 2000; 6:109-114
Article]]> Thomas H Connor, Qian Xiang 2000-09-01 10.1177/107815520000600304 SAGE Publications <![CDATA[Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin, and oxaliplatin during simulated Y-site administration]]> http://opp.sagepub.com/cgi/content/short/10/4/191?rss=1&ssource=mfc Dec 1, 2004; 10:191-195
Article]]> Lawrence A. Trissel, Yanping Zhang 2004-12-01 10.1191/1078155204jp136oa SAGE Publications <![CDATA[Survey of topical oral solutions for the treatment of chemo-induced oral mucositis]]> http://opp.sagepub.com/cgi/content/short/11/4/139?rss=1&ssource=mfc Dec 1, 2005; 11:139-143
Article]]> Alexandre Chan, Robert J. Ignoffo 2005-12-01 10.1191/1078155205jp166oa SAGE Publications <![CDATA[Interstitial lung disease following erlotinib (Tarceva(R)) in a patient who previously tolerated gefitinib (Iressa(R))]]> http://opp.sagepub.com/cgi/content/short/11/3/127?rss=1&ssource=mfc Sep 1, 2005; 11:127-130
Article]]> Kelly A. Tammaro, Patricia D. Baldwin, Ante S. Lundberg 2005-09-01 10.1191/1078155205jp158cr SAGE Publications <![CDATA[Study of the effect of standardized chemotherapy order forms on prescribing errors and anti-emetic cost]]> http://opp.sagepub.com/cgi/content/short/11/1/21?rss=1&ssource=mfc Mar 1, 2005; 11:21-30
Article]]> Harold S Sano, J Aubrey Waddell, Dominic A Solimando Jr, Paula Doulaveris, Rickey Myhand 2005-03-01 10.1191/1078155205jp149oa SAGE Publications <![CDATA[ISOPP "down-under" : A new dawn and widening horizons]]> http://opp.sagepub.com/cgi/content/short/3/1/11?rss=1&ssource=mfc Mar 1, 1997; 3:11-12
Article]]> Graham J Sewell 1997-03-01 10.1177/107815529700300101 SAGE Publications <![CDATA[Our time has arrived!!: Board of Pharmaceutical Specialties approves petition to recognize oncology pharmacy practice as a pharmacy specialty]]> http://opp.sagepub.com/cgi/content/short/2/3/134?rss=1&ssource=mfc Jan 1, 1996; 2:134-135
Article]]> Barry R. Goldspiel 1996-01-01 10.1177/107815529600200301 SAGE Publications <![CDATA[A pharmacokinetic-pharmacodynamic study on carboplatin administered in prolonged continuous infusion regimens with synchronous radiotherapy]]> http://opp.sagepub.com/cgi/content/short/1/3/25?rss=1&ssource=mfc Jan 1, 1995; 1:25-32
Article]]> M.A. Allsopp, G.J. Sewell 1995-01-01 10.1177/107815529500100305 SAGE Publications <![CDATA[Viability of microorganisms in novel antineoplastic and antiviral drug solutions]]> http://opp.sagepub.com/cgi/content/short/4/1/32?rss=1&ssource=mfc Mar 1, 1998; 4:32-37
Article]]> Irene Kramer 1998-03-01 10.1177/107815529800400104 SAGE Publications <![CDATA[A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate `dose-banding']]> http://opp.sagepub.com/cgi/content/short/13/2/119?rss=1&ssource=mfc Jun 1, 2007; 13:119-126
Article]]> Sabine Kaestner, Graham Sewell 2007-06-01 10.1177/1078155207080803 SAGE Publications <![CDATA[Dose-banding of carboplatin: rationale and proposed banding scheme]]> http://opp.sagepub.com/cgi/content/short/13/2/109?rss=1&ssource=mfc Jun 1, 2007; 13:109-117
Article]]> Sabine Kaestner, Graham Sewell 2007-06-01 10.1177/1078155207080801 SAGE Publications <![CDATA[Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival]]> http://opp.sagepub.com/cgi/content/short/13/2/85?rss=1&ssource=mfc Jun 1, 2007; 13:85-97
Article]]> Jennifer Nishioka, Susan Goodin 2007-06-01 10.1177/1078155207079169 SAGE Publications <![CDATA[An evaluation of six infusion devices for the continuous infusion of cytotoxic drugs in ambulatory patients]]> http://opp.sagepub.com/cgi/content/short/1/1/15?rss=1&ssource=mfc Jun 1, 1995; 1:15-22
Article]]> E.M. Hardy, C. Williamson, G.J. Sewell 1995-06-01 10.1177/107815529500100102 SAGE Publications <![CDATA[Physical exercise for cytotoxic drug-induced fatigue]]> http://opp.sagepub.com/cgi/content/short/12/4/183?rss=1&ssource=mfc Dec 1, 2006; 12:183-191
Article]]> Per Hartvig, Johan Aulin, Sofia Wallenberg, Gunnar Wagenius 2006-12-01 10.1177/1078155206070776 SAGE Publications <![CDATA[Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations]]> http://opp.sagepub.com/cgi/content/short/12/2/95?rss=1&ssource=mfc Jun 1, 2006; 12:95-104
Article]]> Sarah Roberts, Nancy Khammo, Gerald McDonnell, Graham J Sewell 2006-06-01 10.1177/1078155206070439 SAGE Publications <![CDATA[An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital]]> http://opp.sagepub.com/cgi/content/short/12/2/75?rss=1&ssource=mfc Jun 1, 2006; 12:75-81
Article]]> Eva Ramme Bremberg, Christina Hising, Urban Nylen, Hans Ehrsson, Staffan Eksborg 2006-06-01 10.1177/1078155206070412 SAGE Publications <![CDATA[Pyridoxine treatment and prevention of hand-and-foot syndrome in patients receiving capecitabine]]> http://opp.sagepub.com/cgi/content/short/9/4/161?rss=1&ssource=mfc Dec 1, 2003; 9:161-166
Article]]> Joanne E Mortimer, Mary Kay Lauman, Benjamin Tan, Cindy L Dempsey, Alicia C Shillington, Kellie S Hutchins 2003-12-01 10.1191/1078155203jp116oa SAGE Publications <![CDATA[Stability and compatibility of 5-fluorouracil infusions in the Braun Easypump(R)]]> http://opp.sagepub.com/cgi/content/short/9/2-3/109?rss=1&ssource=mfc Jun 1, 2003; 9:109-112
Article]]> Sarah Roberts, Graham J Sewell 2003-06-01 10.1191/1078155203jp109oa SAGE Publications <![CDATA[Interacting with drugs used in oncology: an Alberta Cancer Board initiative]]> http://opp.sagepub.com/cgi/content/short/9/2-3/87?rss=1&ssource=mfc Jun 1, 2003; 9:87-107
Article]]> Ashraf Moosa, Roxanne Dobish, Cathy Watts 2003-06-01 10.1191/1078155202jp108oa SAGE Publications <![CDATA[A guide to clinically relevant drug interactions in oncology]]> http://opp.sagepub.com/cgi/content/short/9/2-3/45?rss=1&ssource=mfc Jun 1, 2003; 9:45-85
Article]]> Masha S H Lam, Robert J Ignoffo 2003-06-01 10.1191/1078155203jp107oa SAGE Publications <![CDATA[Physician order entry: a mixed blessing to pharmacy?]]> http://opp.sagepub.com/cgi/content/short/8/4/119?rss=1&ssource=mfc Dec 1, 2002; 8:119-126
Article]]> Jamie Beer, Roxanne Dobish, Carole Chambers 2002-12-01 10.1191/1078155202jp099oa SAGE Publications <![CDATA[Standardization of body surface area calculations]]> http://opp.sagepub.com/cgi/content/short/8/2-3/49?rss=1&ssource=mfc Jun 1, 2002; 8:49-54
Article]]> Thanh T Vu 2002-06-01 10.1191/1078155202jp095oa SAGE Publications <![CDATA[Steady-state pharmacokinetic comparison of a new, once-daily, extended-release morphine formulation (MorphelanTM) and OxyContin(R) twice daily]]> http://opp.sagepub.com/cgi/content/short/7/1/1?rss=1&ssource=mfc Mar 1, 2001; 7:1-8
Article]]> Lise Eliot, Rita Geiser, Gordon Loewen 2001-03-01 10.1191/1078155201jp075oa SAGE Publications <![CDATA[Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices]]> http://opp.sagepub.com/cgi/content/short/5/2/75?rss=1&ssource=mfc Jun 1, 1999; 5:75-82
Article]]> Irene Kramer, Judith Thiesen 1999-06-01 10.1177/107815529900500203 SAGE Publications <![CDATA[Penetration and splash protection of six disposable gown materials against fifteen antineoplastic drugs]]> http://opp.sagepub.com/cgi/content/short/5/2/61?rss=1&ssource=mfc Jun 1, 1999; 5:61-66
Article]]> Bruce R Harrison, Michael D Kloos 1999-06-01 10.1177/107815529900500201 SAGE Publications <![CDATA[Erratum]]> http://opp.sagepub.com/cgi/content/short/10/3/187?rss=1&ssource=mfc Sep 1, 2004; 10:187-187
Article]]> 2004-09-01 10.1177/107815520401000309 SAGE Publications <![CDATA[Retrospective evaluation of response to epoetin alfa in patients with hematologic disorders]]> http://opp.sagepub.com/cgi/content/short/10/1/1?rss=1&ssource=mfc Mar 1, 2004; 10:1-6
Article]]> Jill M Kolesar, Betsy A Duren, Bruce G Baranski 2004-03-01 10.1191/1078155204jp117oa SAGE Publications <![CDATA[Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature]]> http://opp.sagepub.com/cgi/content/short/11/2/69?rss=1&ssource=mfc Jun 1, 2005; 11:69-78
Article]]> George Dranitsaris, Mary Johnston, Susan Poirier, Trudi Schueller, Debbie Milliken, Esther Green, Brent Zanke 2005-06-01 10.1191/1078155205jp155oa SAGE Publications <![CDATA[Vinorelbine and venous irritation: optimal parenteral administration]]> http://opp.sagepub.com/cgi/content/short/11/2/79?rss=1&ssource=mfc Jun 1, 2005; 11:79-81
Article]]> Mario L de Lemos 2005-06-01 10.1191/1078155205jp146oa SAGE Publications <![CDATA[Microbial growth tests in anti-neoplastic injectable solutions]]> http://opp.sagepub.com/cgi/content/short/11/1/7?rss=1&ssource=mfc Mar 1, 2005; 11:7-12
Article]]> Isabelle Paris, Angelo Paci, Jean-Baptiste Rey, Philippe Bourget 2005-03-01 10.1191/1078155205jp143oa SAGE Publications <![CDATA[Overview of drug therapy for multiple myeloma]]> http://opp.sagepub.com/cgi/content/short/11/3/83?rss=1&ssource=mfc Sep 1, 2005; 11:83-100
Article]]> Geoff Saunders 2005-09-01 10.1191/1078155205jp160oa SAGE Publications <![CDATA[Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy]]> http://opp.sagepub.com/cgi/content/short/11/3/111?rss=1&ssource=mfc Sep 1, 2005; 11:111-119
Article]]> Paul H Sugarbaker, O. Anthony Stuart, Dal Yoo 2005-09-01 10.1191/1078155205jp157oa SAGE Publications